1501 related articles for article (PubMed ID: 18664007)
1. Conflicts of interest in research involving human beings.
Greco D; Diniz NM
J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
3. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
4. Committees for Ethics in Research involving human subjects.
Hossne WS; Vieira S; De Freitas CB
J Int Bioethique; 2008; 19(1-2):131-41, 200. PubMed ID: 18664006
[TBL] [Abstract][Full Text] [Related]
5. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
Newcombe JP; Kerridge IH
Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
[TBL] [Abstract][Full Text] [Related]
6. [Medicine: conflicts of interest in research].
Fallena-Zonana M; Kraus-Weisman A
Rev Invest Clin; 2003; 55(3):339-46. PubMed ID: 14515679
[TBL] [Abstract][Full Text] [Related]
7. Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside.
Yim R
Transfusion; 2005 Oct; 45(4 Suppl):144S-58S. PubMed ID: 16181400
[TBL] [Abstract][Full Text] [Related]
8. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical research: paradox, challenge or dilemma?
Sheikh AL
East Mediterr Health J; 2006; 12 Suppl 1():S42-9. PubMed ID: 17037688
[TBL] [Abstract][Full Text] [Related]
10. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
11. Protecting subjects, preserving trust, promoting progress II: principles and recommendations for oversight of an institution's financial interests in human subjects research.
AAMC Task Force on Financial Conflicts of Interest in Clinical Research
Acad Med; 2003 Feb; 78(2):237-45. PubMed ID: 12584107
[TBL] [Abstract][Full Text] [Related]
12. Policies on faculty conflicts of interest at US universities.
Cho MK; Shohara R; Schissel A; Rennie D
JAMA; 2000 Nov; 284(17):2203-8. PubMed ID: 11056591
[TBL] [Abstract][Full Text] [Related]
13. Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators.
Weinfurt KP; Friedman JY; Dinan MA; Allsbrook JS; Hall MA; Dhillon JK; Sugarman J
J Law Med Ethics; 2006; 34(3):581-91, 481. PubMed ID: 17144182
[TBL] [Abstract][Full Text] [Related]
14. Legal and ethical obligations to conduct a clinical drug trial in Australia as an investigator initiated and sponsored study for an overseas pharmaceutical company.
Beran RG
Med Law; 2004; 23(4):913-24. PubMed ID: 15685926
[TBL] [Abstract][Full Text] [Related]
15. The diverse ethics of translational research.
Sofaer N; Eyal N
Am J Bioeth; 2010 Aug; 10(8):19-30. PubMed ID: 20694901
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical companies vs. the State: who is responsible for post-trial provision of drugs in Brazil?
Wang DW; Ferraz OL
J Law Med Ethics; 2012; 40(2):188-96. PubMed ID: 22789039
[TBL] [Abstract][Full Text] [Related]
17. Participants' awareness of ethical compliance, safety and protection during participation in pharmaceutical industry clinical trials: a controlled survey.
González-Saldivar G; Rodríguez-Gutiérrez R; Viramontes-Madrid JL; Salcido-Montenegro A; Álvarez-Villalobos NA; González-Nava V; González-González JG
BMC Med Ethics; 2019 Jan; 20(1):2. PubMed ID: 30621692
[TBL] [Abstract][Full Text] [Related]
18. Defining financial conflicts and managing research relationships: an analysis of university conflict of interest committee decisions.
Boyd EA; Bero LA
Sci Eng Ethics; 2007 Dec; 13(4):415-35. PubMed ID: 18008185
[TBL] [Abstract][Full Text] [Related]
19. [Clinical trials in developing countries: who should define ethics?].
Béréterbide F; Hirsch F
Bull Soc Pathol Exot; 2008 Apr; 101(2):102-5. PubMed ID: 18543701
[TBL] [Abstract][Full Text] [Related]
20. Ethics issues in academic-industry relationships in the life sciences: the continuing debate.
Blumenthal D
Acad Med; 1996 Dec; 71(12):1291-6. PubMed ID: 9114886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
